India to United States: Cefpodoxime Export Trade Route
India has recorded 189 verified shipments of Cefpodoxime exported to United States, representing a combined trade value of $48.3M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $255.5K USD. The leading Indian exporter is ALKEM LABORATORIES LIMITED, which accounts for 57% of total export value with 12 shipments worth $27.5M USD. On the buying side, AMICI PHARMACEUTICALS is the largest importer in United States with $26.8M USD in purchases. The top 3 suppliers — ALKEM LABORATORIES LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Cefpodoxime corridor is one of India's established pharmaceutical export routes, with 189 shipments documented worth a combined $48.3M USD. The route is dominated by ALKEM LABORATORIES LIMITED, which alone accounts for roughly 57% of all export value, reflecting the consolidated nature of India's cefpodoxime manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $255.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #13 among India's top cefpodoxime export destinations globally.
On the import side, key buyers of Indian cefpodoxime in United States include AMICI PHARMACEUTICALS, CRONUS PHARMA LLC, MCKESSON THIRD PARTY LOGISTICS and 23 others. AMICI PHARMACEUTICALS is the single largest importer with 5 shipments valued at $26.8M USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portHYDERABAD ICD
Market Position
- Global rank#13
- Annual growth+22.8%
- Demand growth+21.2%
- Regulatory ease69/100
Top 10 Indian Cefpodoxime Exporters to United States
Showing top 10 of 5 Indian suppliers exporting Cefpodoxime to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LIMITED Avg $2.3M per shipment | 12 | $27.5M | 56.8% |
| 2 | AUROBINDO PHARMA LTD Avg $123.8K per shipment | 111 | $13.7M | 28.5% |
| 3 | AUROBINDO PHARMA LIMITED Avg $111.5K per shipment | 63 | $7.0M | 14.5% |
| 4 | ALKEM LABORATORIES LTD Avg $71.0K per shipment | 1 | $71.0K | 0.1% |
| 5 | VEA IMPEX (I) PRIVATE LIMITED Avg $52 per shipment | 2 | $104 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting cefpodoxime to United States, ranked by total trade value. The listed exporters are: ALKEM LABORATORIES LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, ALKEM LABORATORIES LTD, VEA IMPEX (I) PRIVATE LIMITED. ALKEM LABORATORIES LIMITED is the dominant supplier with 12 shipments worth $27.5M USD, giving it a 57% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Cefpodoxime Importers in United States
Showing top 10 of 26 known buyers in United States receiving Cefpodoxime shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cefpodoxime in United States include AMICI PHARMACEUTICALS, CRONUS PHARMA LLC, MCKESSON THIRD PARTY LOGISTICS, CRONUS PHARMA LLC,, AUROBINDO PHARMA USA.,INC, among 26 total buyers. The largest importer is AMICI PHARMACEUTICALS, accounting for $26.8M USD across 5 shipments — representing 56% of all cefpodoxime imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AMICI PHARMACEUTICALS | 5 | $26.8M | 55.6% |
| 2 | CRONUS PHARMA LLC | 23 | $4.5M | 9.3% |
| 3 | MCKESSON THIRD PARTY LOGISTICS | 8 | $2.5M | 5.2% |
| 4 | CRONUS PHARMA LLC, | 14 | $2.4M | 5.1% |
| 5 | AUROBINDO PHARMA USA.,INC | 16 | $2.2M | 4.5% |
| 6 | AUROLOGISTICS LLC | 5 | $1.9M | 4.0% |
| 7 | AUROBINDO PHARMA USA INC | 11 | $1.9M | 3.9% |
| 8 | NORTHSTAR DISTRIBUTION CENTER 8912 | 49 | $1.7M | 3.5% |
| 9 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 11 | $1.1M | 2.3% |
| 10 | AUROLOGISTICS LLC, | 3 | $779.8K | 1.6% |
Showing top 10 of 26 Cefpodoxime importers in United States on this route.
Top 10 Cefpodoxime Formulations Imported by United States
Showing top 10 of 129 product formulations shipped on the India to United States Cefpodoxime route, ranked by trade value
United States imports a wide range of cefpodoxime formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CEFPO PROX. TABLETS USP 200MG (CEFPODOXIME PROXETIL TABLETS USP 200MG) [970 X 500'S] — accounts for $26.6M USD across 1 shipments. There are 129 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CEFPO PROX. TABLETS USP 200MG (CEFPODOXIME PROXETIL TABLETS USP 200MG) [970 X 500'S] | 1 | $26.6M | 55.1% |
| 2 | CEFPODOXIME PROXETIL TABLETS 200MG (CEFPODOXIME PROXETIL TABLETS USP 200MG) | 10 | $2.6M | 5.4% |
| 3 | CEFPODOXIME PROXETIL TABLETS 200MG Cefpodoxime Proxetil Tablets USP 200 mg | 6 | $2.2M | 4.6% |
| 4 | CEFPODOXIME PROXETIL TABLETS 200MG CEFPODOXIME PROXETIL TABLETS USP 200MG | 4 | $1.5M | 3.2% |
| 5 | CEFPODOXIME PROXETIL TABLETS 200MG (CEFPODOXIME PROXETIL TABLETS USP 200MG)NOS | 3 | $679.0K | 1.4% |
| 6 | CEFPODOXIME PROXETIL TABLETS 200MG (Cefpodoxime Proxetil Tablets USP 200 mg) | 1 | $591.3K | 1.2% |
| 7 | CEFPODOXIME PROXETIL TABLETS 200MG (42432 X 20'S PACKS= 848640 NOS) | 1 | $568.3K | 1.2% |
| 8 | CEFPODOXIME PROXETIL TABLETS 200MG (Cefpodoxime Proxetil Tablets USP 200 mg) (13527 PACK) | 1 | $529.7K | 1.1% |
| 9 | CEFPODOXIME PROXETIL TABLETS USP 200MG (13440 X 100'S PACK) | 1 | $528.5K | 1.1% |
| 10 | CEFPODOXIME PROXETIL TABLETS 200MG (Cefp | 1 | $487.7K | 1.0% |
Showing top 10 of 129 Cefpodoxime formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 47 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's cefpodoxime exports to United States are driven primarily by a handful of large-scale manufacturers. ALKEM LABORATORIES LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ALKEM LABORATORIES LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $255.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as cefpodoxime proxetil tablets 200mg (cefpodoxime proxetil tablets usp 200mg) and cefpodoxime proxetil tablets 200mg cefpodoxime proxetil tablets usp 200 mg, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AMICI PHARMACEUTICALS is the largest importer with 5 shipments worth $26.8M USD — representing 56% of all cefpodoxime imports from India on this route. A total of 26 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $48.3M
- Avg. Shipment
- $255.5K
- Suppliers
- 5
- Buyers
- 26
- Transit (Sea)
- ~25 days
- Annual Growth
- +22.8%
Related Analysis
Reverse Direction
United States → India — Cefpodoxime (Import)Other Cefpodoxime Routes
Cefpodoxime — Export Intelligence Video
Visual overview of India's cefpodoxime India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Cefpodoxime Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 189 shipments on this route.
Frequently Asked Questions — India to United States Cefpodoxime Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cefpodoxime to United States?
The leading Indian exporters of Cefpodoxime to United States are ALKEM LABORATORIES LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED. ALKEM LABORATORIES LIMITED holds the largest market share at approximately 57% of total trade value on this route.
Q What is the total value of Cefpodoxime exports from India to United States?
India exports Cefpodoxime to United States worth approximately $48.3M USD across 189 recorded shipments. The average value per shipment is $255.5K USD.
Q Which ports does India use to ship Cefpodoxime to United States?
The most active port of origin is HYDERABAD ICD with 47 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Cefpodoxime?
The average transit time for Cefpodoxime shipments from India to United States is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Cefpodoxime trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.8% with demand growth tracking at 21.2%. The route is ranked #13 among India's top Cefpodoxime export destinations globally.
Q How many suppliers are active on the India to United States Cefpodoxime route?
There are currently 5 active Indian suppliers exporting Cefpodoxime to United States. The market is moderately concentrated with ALKEM LABORATORIES LIMITED accounting for 57% of total shipment value.
Q Who are the main importers of Cefpodoxime from India in United States?
The leading importers of Indian Cefpodoxime in United States include AMICI PHARMACEUTICALS, CRONUS PHARMA LLC, MCKESSON THIRD PARTY LOGISTICS, CRONUS PHARMA LLC,, AUROBINDO PHARMA USA.,INC. AMICI PHARMACEUTICALS is the largest buyer with 5 shipments worth $26.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Cefpodoxime.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 26 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 189 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
189 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists